雄激素性脱发

Gan DC, Sinclair RD. Prevalence of male and female pattern hair loss in Maryborough. J Investig Dermatol Symp Proc. 2005;10:184-189.

• 全文
• 摘要

Olsen EA, Messenger AG, Shapiro J, et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol. 2005;52:301-311.

• 摘要

Whiting DA, Olsen EA, Savin R, et al. Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss. Eur J Dermatol. 2003;13:150-160.

• 摘要

Blumeyer A, Tosti A, Messenger A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges. 2011;9(suppl 6):1-57.

• 全文
• 摘要

Olsen EA, Whiting D, Bergfeld W, et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2007;57:767-774.

• 摘要

Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47:377-385.

• 摘要

Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol. 1998;39:578-589.

• 摘要

Lucky AW, Piacquadio DJ, Ditre CM, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004;50:541-553.

• 摘要

1.  Hamilton JB. Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci. 1951;53:708-728.

• 摘要

2.  Norwood OT. Male pattern baldness: classification and incidence. South Med J. 1975;68:1359-1365.

• 摘要

3.  Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol. 1977;97:247-254.

• 摘要

4.  Stough D, Stenn K, Haber R, et al. Psychological effects, pathophysiology, and management of androgenic alopecia in men. Mayo Clin Proc. 2005;80:1316-1322.

• 摘要

5.  Gan DC, Sinclair RD. Prevalence of male and female pattern hair loss in Maryborough. J Investig Dermatol Symp Proc. 2005;10:184-189.

• 全文
• 摘要

6.  Rhodes T, Girman CJ, Savin RC, et al. Prevalence of male pattern hair loss in 18-49 year old men. Dermatol Surg.1998;24:1330-1332.

• 摘要

7.  Otberg N, Finner AM, Shapiro J. Androgenetic alopecia. Endocrinol Metabol Clin N Am. 2007;36:379-398.

• 摘要

8.  Venning VA, Dawber RP. Patterned androgenic alopecia in women. J Am Acad Dermatol. 1988;18:1073-1077.

• 摘要

9.  Birch MP, Lalla SC, Messenger AG. Female pattern hair loss. Clin Exp. Dermatol. 2002;27:383-388.

• 摘要

10.  Küster W, Happle R. The inheritance of common baldness: two B or not two B? J Am Acad Dermatol. 1984;11:921-926.

• 摘要

11.  Bergfeld W. Androgenetic alopecia: an autosomal dominant disorder. Am J Med. 1995;98:95S-98S.

• 摘要

12.  Trüeb RM. Molecular mechanism of androgenetic alopecia. Exp Gerontol. 2002;37:981-990.

• 摘要

13.  Olsen EA, Messenger AG, Shapiro J, et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol. 2005;52:301-311.

• 摘要

14.  Itami S, Kurata S, Takayasu S. Androgen induction of follicular epithelial cell growth is mediated via insulin-like growth factor I from dermal papilla cells. Biochem Biophys Res Commun. 1995;26:988-994.

• 摘要

15.  Harris G, Azzolina B, Baginsky W, et al. Identification and selective inhibition of an isoenzyme of steroid 5 alpha -reductase in human scalp. Proc Natl Acad Sci. 1992;89:10787-10791.

• 全文
• 摘要

16.  Chen W, Thiboutot D, Zouboulis CC. Cutaneous androgen metabolism: basic research and clinical perspectives. J Invest Dermatol. 2002;119:992-1007.

• 全文
• 摘要

17.  Raudrant D, Rabe T. Progestogens with antiandrogenic properties. Drugs. 2003;63:463-492.

• 摘要

18.  Giles GG, Severi G, Sinclair R, et al. Androgenetic alopecia and prostate cancer: findings from an Australian case-control study. Cancer Epidemiol Biomarkers Prev. 2002;11:549-53.

• 全文
• 摘要

19.  Whiting DA, Olsen EA, Savin R, et al. Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss. Eur J Dermatol. 2003;13:150-160.

• 摘要

20.  Springer K, Brown M, Stulberg DL. Common hair loss disorders. Am Fam Physician. 2003;68:93-102.

• 全文
• 摘要

21.  Blumeyer A, Tosti A, Messenger A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges. 2011;9(suppl 6):1-57.

• 全文
• 摘要

22.  Shapiro J. Clinical practice. Hair loss in women. N Engl J Med. 2007;357:1620-1630.

• 摘要

23.  Olsen EA, Whiting D, Bergfeld W, et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2007;57:767-774.

• 摘要

24.  Buhl AE, Waldon, DJ, Conrad SJ, et al. Potassium channel conductance: a mechanism affecting hair growth both in vitro and in vivo. J Invest Dermatol. 1992;98:315-319.

• 全文
• 摘要

25.  Price VH, Menefee E, Strauss PC. Changes in hair weight and hair count in men with androgenetic alopecia after application of 5% and 2% topical minoxidil, placebo, or no treatment. J Am Acad Dermatol. 1999;41:717-721.

• 摘要

26.  Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47:377-385.

• 摘要

27.  Tsuboi R, Arano O, Nishikawa T, et al. Randomized clinical trial comparing 5% and 1% topical minoxidil for the treatment of androgenetic alopecia in Japanese men. J Dermatol. 2009;36:437-46.

• 摘要

28.  Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol. 1998;39:578-589.

• 摘要

29.  Gupta AK, Charrette A. The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit-risk assessment of finasteride and dutasteride. J Dermatolog Treat. 2014;25:156-161.

• 全文
• 摘要

30.  Lucky AW, Piacquadio DJ, Ditre CM, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004;50:541-553.

• 摘要

31.  Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol. 2005;152:466-473.

• 摘要

32.  Sadick NS, White MP. Basic hair transplantation: 2007. Dermatol Ther. 2007;20:436-447.

• 摘要

33.  Kim H, Choi JW, Kim JY, et al. Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device-controlled multicenter trial. Dermatol Surg. 2013;39:1177-1183.

• 摘要

34.  Lanzafame RJ, Blanche RR, Bodian AB, et al. The growth of human scalp hair mediated by visible red light laser and LED sources in males. Lasers Surg Med. 2013;45:487-495.

• 摘要

35.  Drake L, Hordinsky M, Fiedler V, et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol. 1999;41:550-554.

• 摘要